Spectral AI posted decreases in its 2023 revenue.
For the fourth quarter of 2023, the company reported a revenue of $5.3 million, compared with $6.1 million for the same period in 2022.
Net loss for the fourth quarter of last year was $3.5 million, compared to a net loss of $1.7 million for the same time period in 2022. For the 2023 fiscal year, the net loss was $20.9 million, compared with a net loss of $2.9 million in 2022. Spectral said the net loss posted for 2023 included $8.3 million of nonrecurring transaction costs associated with the completion of the company’s Nasdaq listing, it said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
